125 related articles for article (PubMed ID: 12119292)
1. cGMP-dependent protein kinase inhibits serum-response element-dependent transcription by inhibiting rho activation and functions.
Gudi T; Chen JC; Casteel DE; Seasholtz TM; Boss GR; Pilz RB
J Biol Chem; 2002 Oct; 277(40):37382-93. PubMed ID: 12119292
[TBL] [Abstract][Full Text] [Related]
2. Vasodilator-stimulated phosphoprotein activation of serum-response element-dependent transcription occurs downstream of RhoA and is inhibited by cGMP-dependent protein kinase phosphorylation.
Zhuang S; Nguyen GT; Chen Y; Gudi T; Eigenthaler M; Jarchau T; Walter U; Boss GR; Pilz RB
J Biol Chem; 2004 Mar; 279(11):10397-407. PubMed ID: 14679200
[TBL] [Abstract][Full Text] [Related]
3. Negative regulation of rho signaling by insulin and its impact on actin cytoskeleton organization in vascular smooth muscle cells: role of nitric oxide and cyclic guanosine monophosphate signaling pathways.
Begum N; Sandu OA; Duddy N
Diabetes; 2002 Jul; 51(7):2256-63. PubMed ID: 12086958
[TBL] [Abstract][Full Text] [Related]
4. RhoGEF17, a Rho-specific guanine nucleotide exchange factor activated by phosphorylation via cyclic GMP-dependent kinase Iα.
Lutz S; Mohl M; Rauch J; Weber P; Wieland T
Cell Signal; 2013 Mar; 25(3):630-8. PubMed ID: 23195829
[TBL] [Abstract][Full Text] [Related]
5. The RhoA/Rho kinase pathway regulates nuclear localization of serum response factor.
Liu HW; Halayko AJ; Fernandes DJ; Harmon GS; McCauley JA; Kocieniewski P; McConville J; Fu Y; Forsythe SM; Kogut P; Bellam S; Dowell M; Churchill J; Lesso H; Kassiri K; Mitchell RW; Hershenson MB; Camoretti-Mercado B; Solway J
Am J Respir Cell Mol Biol; 2003 Jul; 29(1):39-47. PubMed ID: 12600823
[TBL] [Abstract][Full Text] [Related]
6. L-type voltage-gated Ca2+ channels modulate expression of smooth muscle differentiation marker genes via a rho kinase/myocardin/SRF-dependent mechanism.
Wamhoff BR; Bowles DK; McDonald OG; Sinha S; Somlyo AP; Somlyo AV; Owens GK
Circ Res; 2004 Aug; 95(4):406-14. PubMed ID: 15256479
[TBL] [Abstract][Full Text] [Related]
7. CCG-1423: a small-molecule inhibitor of RhoA transcriptional signaling.
Evelyn CR; Wade SM; Wang Q; Wu M; Iñiguez-Lluhí JA; Merajver SD; Neubig RR
Mol Cancer Ther; 2007 Aug; 6(8):2249-60. PubMed ID: 17699722
[TBL] [Abstract][Full Text] [Related]
8. Differential usage of signal transduction pathways defines two types of serum response factor target gene.
Gineitis D; Treisman R
J Biol Chem; 2001 Jul; 276(27):24531-9. PubMed ID: 11342553
[TBL] [Abstract][Full Text] [Related]
9. Cyclic GMP kinase and RhoA Ser188 phosphorylation integrate pro- and antifibrotic signals in blood vessels.
Sawada N; Itoh H; Miyashita K; Tsujimoto H; Sone M; Yamahara K; Arany ZP; Hofmann F; Nakao K
Mol Cell Biol; 2009 Nov; 29(22):6018-32. PubMed ID: 19737918
[TBL] [Abstract][Full Text] [Related]
10. cGMP-dependent protein kinase phosphorylates and inactivates RhoA.
Sawada N; Itoh H; Yamashita J; Doi K; Inoue M; Masatsugu K; Fukunaga Y; Sakaguchi S; Sone M; Yamahara K; Yurugi T; Nakao K
Biochem Biophys Res Commun; 2001 Jan; 280(3):798-805. PubMed ID: 11162591
[TBL] [Abstract][Full Text] [Related]
11. RhoA expression is controlled by nitric oxide through cGMP-dependent protein kinase activation.
Sauzeau V; Rolli-Derkinderen M; Marionneau C; Loirand G; Pacaud P
J Biol Chem; 2003 Mar; 278(11):9472-80. PubMed ID: 12524425
[TBL] [Abstract][Full Text] [Related]
12. Galphaz inhibits serum response factor-dependent transcription by inhibiting Rho signaling.
Dutt P; Jaffe AB; Merdek KD; Hall A; Toksoz D
Mol Pharmacol; 2004 Dec; 66(6):1508-16. PubMed ID: 15326221
[TBL] [Abstract][Full Text] [Related]
13. Chronic hypoxia augments protein kinase G-mediated Ca2+ desensitization in pulmonary vascular smooth muscle through inhibition of RhoA/Rho kinase signaling.
Jernigan NL; Walker BR; Resta TC
Am J Physiol Lung Cell Mol Physiol; 2004 Dec; 287(6):L1220-9. PubMed ID: 15310556
[TBL] [Abstract][Full Text] [Related]
14. Cyclic GMP-dependent protein kinase signaling pathway inhibits RhoA-induced Ca2+ sensitization of contraction in vascular smooth muscle.
Sauzeau V; Le Jeune H; Cario-Toumaniantz C; Smolenski A; Lohmann SM; Bertoglio J; Chardin P; Pacaud P; Loirand G
J Biol Chem; 2000 Jul; 275(28):21722-9. PubMed ID: 10783386
[TBL] [Abstract][Full Text] [Related]
15. Sphingosine 1-phosphate stimulates smooth muscle cell differentiation and proliferation by activating separate serum response factor co-factors.
Lockman K; Hinson JS; Medlin MD; Morris D; Taylor JM; Mack CP
J Biol Chem; 2004 Oct; 279(41):42422-30. PubMed ID: 15292266
[TBL] [Abstract][Full Text] [Related]
16. A role of STAT3 in Rho GTPase-regulated cell migration and proliferation.
Debidda M; Wang L; Zang H; Poli V; Zheng Y
J Biol Chem; 2005 Apr; 280(17):17275-85. PubMed ID: 15705584
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of sustained smooth muscle contraction by PKA and PKG preferentially mediated by phosphorylation of RhoA.
Murthy KS; Zhou H; Grider JR; Makhlouf GM
Am J Physiol Gastrointest Liver Physiol; 2003 Jun; 284(6):G1006-16. PubMed ID: 12736149
[TBL] [Abstract][Full Text] [Related]
18. Serum response factor activation by muscarinic receptors via RhoA. Novel pathway specific to M1 subtype involving calmodulin, calcineurin, and Pyk2.
Lin K; Wang D; Sadée W
J Biol Chem; 2002 Oct; 277(43):40789-98. PubMed ID: 12200418
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of RhoA-mediated SRF activation by p116Rip.
Mulder J; Ariaens A; van Horck FP; Moolenaar WH
FEBS Lett; 2005 Nov; 579(27):6121-7. PubMed ID: 16243315
[TBL] [Abstract][Full Text] [Related]
20. The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton.
Leung T; Chen XQ; Manser E; Lim L
Mol Cell Biol; 1996 Oct; 16(10):5313-27. PubMed ID: 8816443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
